Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2004 Feb 23;14(4):913-7.

A new series of potent oxindole inhibitors of CDK2.

Author information

1
Hoffmann-La Roche Inc., 340 Kingsland St., Nutley, NJ 07110-1199, USA.

Abstract

A novel series of oxindole-type inhibitors of CDK2 that have heteroatom substituted alkynyl moieties at their C-4 position is described. These novel 4-alkynyl-substituted inhibitors have superior potency relative to their parent compound in free enzyme and in cell based assays. The crystal structure of CDK2 in complex with one of these analogues was determined and gives insight to their increased potency. The biochemical evaluation of a representative derivative is also described.

PMID:
15012993
DOI:
10.1016/j.bmcl.2003.12.009
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center